Specify a stock or a cryptocurrency in the search bar to get a summary
RPG Life Sciences Limited
RPGLIFERPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust. Address: RPG House, Mumbai, India, 400030
Analytics
WallStreet Target Price
40 359.09 INRP/E ratio
50.5011Dividend Yield
0.75 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures RPGLIFE
Dividend Analytics RPGLIFE
Dividend growth over 5 years
400 %Continuous growth
4 yearsPayout Ratio 5 years average
30 %Dividend History RPGLIFE
Stock Valuation RPGLIFE
Financials RPGLIFE
Results | 2019 | Dynamics |